The results demonstrated that in certain specific tumor types, such as bladder urothelial carcinoma, breast invasive carcinoma, and lung squamous cell carcinoma, as the tumor stage progressed, there was a notable decrease in LINC-PINT expression. This evidence concerns the gene LINC-PINT and invasive breast carcinoma.